{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T12:18:48Z","timestamp":1769084328394,"version":"3.49.0"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"vor","delay-in-days":1980,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2020,7,18]],"date-time":"2020-07-18T00:00:00Z","timestamp":1595030400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Soluble suppression of tumourigenicity 2 (sST2) and catestatin (CST) reflect myocardial fibrosis and sympathetic overactivity during the acute worsening of heart failure (AWHF). We aimed to determine serum levels and associations of sST2 and CST with in-hospital death as well as the association between sST2 and CST among AWHF patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>A total of 96 AWHF patients were consecutively enrolled, while levels of sST2 and CST were determined and compared between non-survivors and survivors. Predictive values of sST2 and CST for in-hospital death were determined by the penalized multivariable Firth logistic regression. The diagnostic ability of sST2 and CST for in-hospital death was assessed by the receiver operating characteristic analysis and examined with respect to the N-terminal pro-brain natriuretic peptide (NT-proBNP), high-sensitivity cardiac troponin I, and C-reactive protein. The in-hospital death rate was 6.25%. Serum sST2 and CST levels were significantly higher among non-survivors than survivors [146.6 (inter-quartile range, IQR 65.9\u2013156.2) vs. 35.3 (IQR 20.6\u201364.4) ng\/mL, P &amp;lt; 0.001, and 19.8 (IQR 9.9\u201328.0) vs. 5.6 (IQR 3.4\u20139.8) ng\/mL, P &amp;lt; 0.001, respectively]. Both sST2 and CST were independent predictors of in-hospital death [Firth coefficient (FC) 6.00, 95% confidence interval (CI), 1.48\u201315.20, P = 0.005, and FC 6.58, 95% CI 1.66\u201321.78, P = 0.003, respectively], while NT-proBNP was not a significant predictor (FC 1.57, 95% CI 0.51\u20133.99, P = 0.142). In classifying non-survivors from survivors, sST2 provided area under the curve (AUC) of 0.917 (95% CI 0.819\u20131.000, P &amp;lt; 0.001) followed by CST (AUC 0.905, 95% CI 0.792\u20131.000, P &amp;lt; 0.001), while NT-proBNP yielded AUC of 0.735 (95% CI 0.516\u20130.954, P = 0.036). High-sensitivity cardiac troponin I and C-reactive protein were not found as significant classifiers of in-hospital death (AUC 0.719, 95% CI 0.509\u20130.930, P = 0.075, and AUC 0.682, 95% CI 0.541\u20130.822, P = 0.164, respectively). Among survivors, those with sST2 serum levels \u226535 ng\/mL had significantly higher CST levels, compared with those with sST2 &amp;lt; 35 ng\/mL (9.05 \u00b1 5.17 vs. 5.06 \u00b1 2.76 ng\/mL, P &amp;lt; 0.001). Serum sST2 levels positively and independently correlated with CST levels in the whole patient cohort (\u03b2 = 0.437, P &amp;lt; 0.001).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Elevated sST2 and CST levels, reflecting two distinct pathophysiological pathways in heart failure, might indicate impending clinical deterioration among AWHF patients during hospitalization and facilitate prognosis beyond traditional biomarkers regarding the risk of in-hospital death (CATSTAT-HF ClinicalTrials.gov Number NCT03389386).<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ehf2.12882","type":"journal-article","created":{"date-parts":[[2020,7,18]],"date-time":"2020-07-18T06:25:10Z","timestamp":1595053510000},"page":"2818-2828","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Circulating sST2 and Catestatin Levels in Patients with Acute Worsening of Heart Failure: A Report from the CATSTAT-HF Study"],"prefix":"10.1093","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4878-8146","authenticated-orcid":false,"given":"Josip A.","family":"Borovac","sequence":"first","affiliation":[{"name":"Department of Pathophysiology, University of Split School of Medicine , Soltanska 2, Split, 21000 ,","place":["Croatia"]},{"name":"Institute of Emergency Medicine of Split-Dalmatia County , Split ,","place":["Croatia"]},{"name":"Clinic for Cardiovascular Diseases, University Hospital of Split , Split ,","place":["Croatia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duska","family":"Glavas","sequence":"additional","affiliation":[{"name":"Clinic for Cardiovascular Diseases, University Hospital of Split , Split ,","place":["Croatia"]},{"name":"Department of Internal Medicine, University of Split School of Medicine , Split ,","place":["Croatia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zora","family":"Susilovic Grabovac","sequence":"additional","affiliation":[{"name":"Clinic for Cardiovascular Diseases, University Hospital of Split , Split ,","place":["Croatia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Supe Domic","sequence":"additional","affiliation":[{"name":"Department of Medical Laboratory Diagnostics, University Hospital of Split , Split ,","place":["Croatia"]},{"name":"Department of Health Studies, University of Split , Split ,","place":["Croatia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lada","family":"Stanisic","sequence":"additional","affiliation":[{"name":"Department of Medical Laboratory Diagnostics, University Hospital of Split , Split ,","place":["Croatia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Domenico","family":"D'Amario","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular and Thoracic Sciences, IRCCS Fondazione Policlinico A. Gemelli, Universit\u00e0 Cattolica del Sacro Cuore , Rome ,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun S.","family":"Kwok","sequence":"additional","affiliation":[{"name":"University Hospitals of North Midlands Royal Stoke University Hospital , Stoke-on-Trent ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josko","family":"Bozic","sequence":"additional","affiliation":[{"name":"Department of Pathophysiology, University of Split School of Medicine , Soltanska 2, Split, 21000 ,","place":["Croatia"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2020,7,18]]},"reference":[{"key":"2026012114065103700_ehf212882-bib-0001","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/ejhf.592","article-title":"2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"18","author":"Ponikowski","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"2026012114065103700_ehf212882-bib-0002","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.jchf.2016.02.017","article-title":"Precipitating clinical factors, heart failure characterization, and outcomes in patients hospitalized with heart failure with reduced, borderline, and preserved ejection fraction","volume":"4","author":"Kapoor","year":"2016","journal-title":"JACC Heart Fail"},{"key":"2026012114065103700_ehf212882-bib-0003","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/ejhf.682","article-title":"Precipitating factors and 90-day outcome of acute heart failure: a report from the intercontinental GREAT registry","volume":"19","author":"Arrigo","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"2026012114065103700_ehf212882-bib-0004","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S0002-9149(01)01683-6","article-title":"Precipitating factors and decision-making processes of short-term worsening heart failure despite \u201coptimal\u201d treatment (from the IN-CHF Registry)","volume":"88","author":"Opasich","year":"2001","journal-title":"Am J Cardiol"},{"key":"2026012114065103700_ehf212882-bib-0005","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.recesp.2014.11.009","article-title":"Acute heart failure: epidemiology, risk factors, and prevention","volume":"68","author":"Farmakis","year":"2015","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"2026012114065103700_ehf212882-bib-0006","doi-asserted-by":"crossref","first-page":"R291","DOI":"10.1186\/cc10584","article-title":"Baseline characteristics and hospital mortality in the Acute Heart Failure Database (AHEAD) Main registry","volume":"15","author":"Spinar","year":"2011","journal-title":"Crit Care"},{"key":"2026012114065103700_ehf212882-bib-0007","first-page":"433","article-title":"I Brazilian registry of heart failure\u2014clinical aspects, care quality and hospitalization outcomes","volume":"104","author":"Albuquerque","year":"2015","journal-title":"Arq Bras Cardiol"},{"key":"2026012114065103700_ehf212882-bib-0008","first-page":"321","article-title":"Causes and predictors of in-hospital mortality in patients admitted with or for heart failure at a tertiary hospital in Brazil","volume":"109","author":"Wajner","year":"2017","journal-title":"Arq Bras Cardiol"},{"key":"2026012114065103700_ehf212882-bib-0009","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.ahj.2010.02.023","article-title":"Causes of death and rehospitalization in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction: results from Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) program","volume":"159","author":"O'Connor","year":"2010","journal-title":"Am Heart J"},{"key":"2026012114065103700_ehf212882-bib-0010","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.hfc.2017.08.005","article-title":"Soluble ST2 in heart failure","volume":"14","author":"McCarthy","year":"2018","journal-title":"Heart Fail Clin"},{"key":"2026012114065103700_ehf212882-bib-0011","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jacc.2007.05.014","article-title":"Measurement of the interleukin family member ST2 in patients with acute dyspnea: results from the PRIDE (Pro-Brain Natriuretic Peptide Investigation of Dyspnea in the Emergency Department) Study","volume":"50","author":"Januzzi","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"2026012114065103700_ehf212882-bib-0012","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1016\/j.jacc.2017.09.026","article-title":"Prognostic value of serial ST2 measurements in patients with acute heart failure","volume":"70","author":"van Vark","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2026012114065103700_ehf212882-bib-0013","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1016\/j.ihj.2017.09.010","article-title":"Prognostic value of soluble ST2 biomarker in heart failure patients with reduced ejection fraction\u2014a multicenter study","volume":"70","author":"Bahuleyan","year":"2018","journal-title":"Indian Heart J"},{"key":"2026012114065103700_ehf212882-bib-0014","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1016\/j.jacc.2009.07.041","article-title":"Soluble ST2 for predicting sudden cardiac death in patients with chronic heart failure and left ventricular systolic dysfunction","volume":"54","author":"Pascual-Figal","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"2026012114065103700_ehf212882-bib-0015","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.peptides.2016.10.007","article-title":"The predictive value of plasma catestatin for all-cause and cardiac deaths in chronic heart failure patients","volume":"86","author":"Peng","year":"2016","journal-title":"Peptides"},{"key":"2026012114065103700_ehf212882-bib-0016","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8081132","article-title":"Catestatin in acutely decompensated heart failure patients: insights from the CATSTAT-HF study","volume":"8","author":"Borovac","year":"2019","journal-title":"J Clin Med"},{"key":"2026012114065103700_ehf212882-bib-0017","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jchf.2016.12.016","article-title":"Meta-analysis of soluble suppression of tumorigenicity-2 and prognosis in acute heart failure","volume":"5","author":"Aimo","year":"2017","journal-title":"JACC Heart Fail"},{"key":"2026012114065103700_ehf212882-bib-0018","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jchf.2016.09.010","article-title":"Prognostic value of soluble suppression of tumorigenicity-2 in chronic heart failure: a meta-analysis","volume":"5","author":"Aimo","year":"2017","journal-title":"JACC Heart Fail"},{"key":"2026012114065103700_ehf212882-bib-0019","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1016\/j.jacc.2018.08.2165","article-title":"sST2 predicts outcome in chronic heart failure beyond NT-proBNP and high-sensitivity troponin T","volume":"72","author":"Emdin","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2026012114065103700_ehf212882-bib-0020","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1093\/cvr\/cvn155","article-title":"Catestatin is a novel endogenous peptide that regulates cardiac function and blood pressure","volume":"80","author":"Mahapatra","year":"2008","journal-title":"Cardiovasc Res"},{"key":"2026012114065103700_ehf212882-bib-0021","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.2174\/0929867324666170425100416","article-title":"Catestatin: a master regulator of cardiovascular functions","volume":"25","author":"Mahata","year":"2018","journal-title":"Curr Med Chem"},{"key":"2026012114065103700_ehf212882-bib-0022","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s11010-019-03661-1","article-title":"Catestatin reverses the hypertrophic effects of norepinephrine in H9c2 cardiac myoblasts by modulating the adrenergic signaling","volume":"464","author":"Alam","year":"2020","journal-title":"Mol Cell Biochem"},{"key":"2026012114065103700_ehf212882-bib-0023","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.regpep.2010.05.005","article-title":"The interplay between chromogranin A-derived peptides and cardiac natriuretic peptides in cardioprotection against catecholamine-evoked stress","volume":"165","author":"Mazza","year":"2010","journal-title":"Regul Pept"},{"key":"2026012114065103700_ehf212882-bib-0024","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.peptides.2014.02.016","article-title":"Usefulness of catestatin to predict malignant arrhythmia in patients with acute myocardial infarction","volume":"55","author":"Pei","year":"2014","journal-title":"Peptides"},{"key":"2026012114065103700_ehf212882-bib-0025","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1177\/1074248416628676","article-title":"Chronic administration of catestatin improves autonomic function and exerts cardioprotective effects in myocardial infarction rats","volume":"21","author":"Wang","year":"2016","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"2026012114065103700_ehf212882-bib-0026","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s12265-014-9563-7","article-title":"Cardiac electrical activity in a genomically \u201chumanized\u201d chromogranin a monogenic mouse model with hyperadrenergic hypertension","volume":"7","author":"Dev","year":"2014","journal-title":"J Cardiovasc Transl Res"},{"key":"2026012114065103700_ehf212882-bib-0027","first-page":"135","article-title":"Sudden cardiac death in heart failure","volume":"32","author":"Klein","year":"2014","journal-title":"Cardiol Clin"},{"key":"2026012114065103700_ehf212882-bib-0028","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1093\/eurheartj\/ehz553","article-title":"What causes sudden death in patients with chronic heart failure and a reduced ejection fraction?","volume":"41","author":"Packer","year":"2019","journal-title":"Eur Heart J"},{"key":"2026012114065103700_ehf212882-bib-0029","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1515\/cclm-2014-1271","article-title":"Elevations of inflammatory markers PTX3 and sST2 after resuscitation from cardiac arrest are associated with multiple organ dysfunction syndrome and early death","volume":"53","author":"Ristagno","year":"2015","journal-title":"Clin Chem Lab Med"},{"key":"2026012114065103700_ehf212882-bib-0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0203363","article-title":"Biomarkers as predictors of sudden cardiac death in coronary artery disease patients with preserved left ventricular function (ARTEMIS study)","volume":"13","author":"Lepojarvi","year":"2018","journal-title":"PLoS ONE"},{"key":"2026012114065103700_ehf212882-bib-0031","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s12265-016-9713-1","article-title":"Soluble ST2 and risk of arrhythmias, heart failure, or death in patients with mildly symptomatic heart failure: results from MADIT-CRT","volume":"9","author":"Skali","year":"2016","journal-title":"J Cardiovasc Transl Res"}],"container-title":["ESC Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fehf2.12882","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ehf2.12882","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/ehf2.12882","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/7\/5\/2818\/65807153\/eschf_7_5_2818.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/7\/5\/2818\/65807153\/eschf_7_5_2818.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T19:07:24Z","timestamp":1769022444000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eschf\/article\/7\/5\/2818\/8372134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,18]]},"references-count":31,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2020,7,18]]},"published-print":{"date-parts":[[2020,10,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ehf2.12882","relation":{},"ISSN":["2055-5822"],"issn-type":[{"value":"2055-5822","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,10]]},"published":{"date-parts":[[2020,7,18]]},"assertion":[{"value":"2020-02-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-06-17","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-07-18","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}